EUVIMEDEUVIMED entdecken
Crossref

Contemporary outcomes of esophageal and gastroesophageal junction neuroendocrine tumors

Lauren M Poston, Shreya Gupta, Christine E Alvarado iD, Jillian Sinopoli, Leonidas T Vargas, Philip A Linden, Christopher W Towe iD

Diseases of the Esophagus · 27.07.2023 · 36 (8)

DOI: 10.1093/dote/doad001 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diseases of the Esophagus, online erschienen am 22.01.2023. Verfasst von Lauren M Poston und 6 weiteren Autor:innen. Beteiligte Einrichtung: Case Western Reserve University School of Medicine, Cleveland, OH, USA. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Adenocarcinoma, Neuroendocrine Tumors. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Adenocarcinoma and squamous cell esophageal cancers have been extensively studied in the literature. Esophageal neuroendocrine (NET)/carcinoid tumors are less commonly studied and have only been described in small series. The purpose of this study was to describe the demographics and natural history of esophageal NETs, as well as optimal treatments. We hypothesized that surgical resection would be the best treatment of esophageal NETs. The National Cancer Database was used to identify adult patients with esophageal or gastroesophageal junction (GEJ) cancer from 2004 to 2018. Patients were characterized as carcinoid/NET, adenocarcinoma, or squamous cell cancer. Clinical and demographic characteristics were compared between the histology groups. The primary outcome was overall survival, which was assessed by multivariable Cox analysis. Multivariable Cox analysis was also used to analyze factors associated with survival among NET patients who underwent surgery. Among 206,321 patients with esophageal cancer, 1,563 were NETs (<0.01%). Relative to the other two histologies, NETs were associated with younger age, female sex, and advanced clinical stage at diagnosis. Multivariate analysis suggested that NETs were less likely to be treated with surgical resection (OR 0.51, P < 0.001). Nonetheless, surgical resection was associated with improved survival (HR 0.64, P = 0.003). Among patients with NETs who received surgery, neoadjuvant therapy was associated with improved overall survival (HR 0.38, P = 0.013). NET of the esophagus presents with more advanced disease than other common histologies. Among patients with nonmetastatic cancer, surgical resection appears to be the best treatment. Neoadjuvant systemic therapy may offer survival benefit, but future studies are necessary.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsAdenocarcinomaNeuroendocrine TumorsAdultRetrospective StudiesEsophagogastric JunctionNeoadjuvant TherapyStomach NeoplasmsFemaleIntestinal NeoplasmsNeoplasm StagingHumansEsophagectomyPancreatic Neoplasms

Stichwörter der Autor:innen

esophageal cancer surgeryesophageal cancersneuroendocrine cancersurgical pathology

Autor:innen und Institutionen

  • Case Western Reserve University School of Medicine, Cleveland, OH, USA.
  • Division of Thoracic and Esophageal Surgery, Department of Surgery, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.

ORCID-Profile: Christine E Alvarado, Christopher W Towe

Zitieren

APA

Poston, L. M., Gupta, S., Alvarado, C. E., Sinopoli, J., Vargas, L. T., Linden, P. A., & Towe, C. W. (2023). Contemporary outcomes of esophageal and gastroesophageal junction neuroendocrine tumors. Diseases of the Esophagus, 36(8). https://doi.org/10.1093/dote/doad001

Vancouver

Poston LM, Gupta S, Alvarado CE, Sinopoli J, Vargas LT, Linden PA, et al. Contemporary outcomes of esophageal and gastroesophageal junction neuroendocrine tumors. Diseases of the Esophagus. 2023;36(8). doi:10.1093/dote/doad001

BibTeX
@article{Poston2023,
  author = {Poston, Lauren M and Gupta, Shreya and Alvarado, Christine E and Sinopoli, Jillian and Vargas, Leonidas T and Linden, Philip A and Towe, Christopher W},
  title = {Contemporary outcomes of esophageal and gastroesophageal junction neuroendocrine tumors},
  journal = {Diseases of the Esophagus},
  year = {2023},
  volume = {36},
  number = {8},
  doi = {10.1093/dote/doad001}
}
Kostenlos starten →